Intra-Cellular Therapies Inc header image

Intra-Cellular Therapies Inc

ITCI

Equity

ISIN null / Valor 23194616

NASDAQ (2025-04-03)

USD 131.87%

Intra-Cellular Therapies Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Intra-Cellular Therapies Inc is a biopharmaceutical company that focuses on developing therapies based on Dr. Paul Greengard's Nobel Prize-winning research on the inner workings of cells in the body. The company is led by experienced industry professionals and scientific advisors, aiming to bring innovative treatments to market for various medical conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

95.9%1Y

110%3Y

816%5Y

Performance

6.70%1Y

42.5%3Y

46.8%5Y

Volatility

8996 M

Market cap (USD)

Daily traded volume (Shares)

84.6 / 82.43

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

MedNation AG

MedNation AG Valor: 331107

Annual Return

-50%0%+50%

Risk level

110

6.55%EUR 3.58

SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA Valor: 128964250

Annual Return

-50%0%+50%

Risk level

110

0.40%EUR 15.08

CorVel Corp

CorVel Corp Valor: 921843

Annual Return

-50%0%+50%

Risk level

110

0.61%USD 49.50

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Inc Valor: 115580129

Annual Return

-50%0%+50%

Risk level

110

0.07%USD 14.13

Bristol-Myers Squibb Co

Bristol-Myers Squibb Co Valor: 914188

Annual Return

-50%0%+50%

Risk level

110

-0.64%USD 60.35

Merck KGaA

Merck KGaA Valor: 412799

Annual Return

-50%0%+50%

Risk level

110

0.63%EUR 127.00

RHOEN-KLINIKUM AG

RHOEN-KLINIKUM AG Valor: 341644

Annual Return

-50%0%+50%

Risk level

110

0.00%EUR 13.00

Boston Scientific Corp

Boston Scientific Corp Valor: 913577

Annual Return

-50%0%+50%

Risk level

110

2.09%USD 76.29

McKesson Corp

McKesson Corp Valor: 991041

Annual Return

-50%0%+50%

Risk level

110

1.25%USD 946.47

Sotera Health Company

Sotera Health Company Valor: 57897071

Annual Return

-50%0%+50%

Risk level

110

-0.18%USD 17.09

SIX

FactSet

Clearbit

Logos provided by Clearbit